Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Schiffmann

Showing results (11-20 of 225) with videos related to

Pageof 23
Sort By:
Pediatric Neurology|August 25, 2016
Fabry Disease: A Disorder of Childhood OnsetRaphael Schiffmann, Markus Ries
Annals of Neurology|March 26, 2013
Reply: To PMID 23034915Fanny Mochel, Raphael Schiffmann
Neurology|December 21, 2014
Leukoencephalopathy: "Before concluding treatment efficacy..."Don Gilden, Raphael Schiffmann
Lancet (London, England)|November 22, 2005
Fabry's disease--an important risk factor for strokeRaphael Schiffmann, Markus Ries
Archives of Dermatology|July 20, 2005
Fabry disease: angiokeratoma, biomarker, and the effect of enzyme replacement therapy on kidney functionMarkus Ries, Raphael Schiffmann
Neurology|July 22, 2016
Brain MRI and motor function in leukodystrophiesRaphael Schiffmann, Brenda Banwell
Molecular Genetics and Metabolism|December 28, 2005
Childhood ataxia with CNS hypomyelination/vanishing white matter disease--a common leukodystrophy caused by abnormal control of protein synthesisRaphael Schiffmann, Orna Elroy-Stein
The Lancet. Neurology|November 24, 2004
Enzyme-replacement therapy for metabolic storage disordersRoscoe O Brady, Raphael Schiffmann
Drugs|April 4, 2002
New prospects for the treatment of lysosomal storage diseasesRaphael Schiffmann, Roscoe O Brady
Advances in Neurology|April 24, 2002
Myoclonus in Gaucher diseaseKaren P Frei, Raphael Schiffmann
Pageof 23

Showing results (11-20 of 225) with videos related to

Sort By:
Pageof 23
Pediatric Neurology|August 25, 2016
Fabry Disease: A Disorder of Childhood OnsetRaphael Schiffmann, Markus Ries
Annals of Neurology|March 26, 2013
Reply: To PMID 23034915Fanny Mochel, Raphael Schiffmann
Neurology|December 21, 2014
Leukoencephalopathy: "Before concluding treatment efficacy..."Don Gilden, Raphael Schiffmann
Lancet (London, England)|November 22, 2005
Fabry's disease--an important risk factor for strokeRaphael Schiffmann, Markus Ries
Archives of Dermatology|July 20, 2005
Fabry disease: angiokeratoma, biomarker, and the effect of enzyme replacement therapy on kidney functionMarkus Ries, Raphael Schiffmann
Neurology|July 22, 2016
Brain MRI and motor function in leukodystrophiesRaphael Schiffmann, Brenda Banwell
Molecular Genetics and Metabolism|December 28, 2005
Childhood ataxia with CNS hypomyelination/vanishing white matter disease--a common leukodystrophy caused by abnormal control of protein synthesisRaphael Schiffmann, Orna Elroy-Stein
The Lancet. Neurology|November 24, 2004
Enzyme-replacement therapy for metabolic storage disordersRoscoe O Brady, Raphael Schiffmann
Drugs|April 4, 2002
New prospects for the treatment of lysosomal storage diseasesRaphael Schiffmann, Roscoe O Brady
Advances in Neurology|April 24, 2002
Myoclonus in Gaucher diseaseKaren P Frei, Raphael Schiffmann
Pageof 23